MAXONA Pharmaceuticals today announced that it has emerged from stealth with the completion of the U.S. Phase 1 clinical development program for the company's first to market product, MAX-001, as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback